Search hospitals > Michigan > Lansing
Sparrow Hospital
Claim this profileLansing, Michigan 48912
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Breast Cancer
371 reported clinical trials
10 medical researchers
Summary
Sparrow Hospital is a medical facility located in Lansing, Michigan. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Adenocarcinoma, Breast Cancer and other specialties. Sparrow Hospital is involved with conducting 371 clinical trials across 535 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
Stage III
Stage I
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
69 reported clinical trials
127 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
45 reported clinical trials
99 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Multiple Myeloma
34 reported clinical trials
94 drugs studied
Clinical Trials running at Sparrow Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Colorectal Cancer
Prostate Cancer
Gastric Cancer
Multiple Myeloma
Urothelial Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sparrow Hospital?
Sparrow Hospital is a medical facility located in Lansing, Michigan. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Adenocarcinoma, Breast Cancer and other specialties. Sparrow Hospital is involved with conducting 371 clinical trials across 535 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Sparrow Hospital located?
**Directions to Sparrow Hospital, Lansing, Michigan:**
- From I-496 W, take exit 7 for US-127 N towards East Lansing.
- Merge onto US-127 N using the left lane and continue for 2 miles.
- Take exit 9 for Trowbridge Rd, turn right onto E Michigan Ave, and the hospital will be on your left after 0.5 miles.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Sparrow Hospital, please contact the following:
- Financial Assistance and Sparrow Health System Inquiries: 517.364.8432 or toll-free at 877.275.0076.
- Insurance-Related Inquiries: 517.364.8456.
Sparrow Health System offers financial assistance to eligible patients, determined by family size and household income.
What insurance does Sparrow Hospital accept?
Sparrow Hospital, part of the MyMichigan Health network, accepts a wide range of insurance plans, including but not limited to Aetna, Blue Care Network, Blue Cross Blue Shield of Michigan, Cigna-Priority Health Strategic Alliance, and United Health Care. It is important to verify with your provider's office about their participation in your insurance plan before scheduling an appointment. Sparrow Health System also offers comprehensive benefits for its employees, encompassing health, dental, and vision options, income protection, retirement savings plans, and more.
What awards or recognition has Sparrow Hospital received?
Sparrow Hospital, located in Lansing, Michigan, is renowned for its significant contributions to health disparities research, earning a national quality improvement award in 2017. Furthermore, Sparrow Health System has been honored with 10 awards by Professional Research Consultants, Inc. for exceptional patient satisfaction, underscoring its dedication to delivering high-quality care.